PeptideWeight loss

Retatrutide

Also called LY3437943

An experimental once-a-week "triple agonist" (GLP-1, GIP and glucagon) for weight loss.

Usual amount
2–12 mg
commonly reported
How it’s taken
Injection under the skin
Half-life
about 6 days
half of it gone after
Good after mixing
28 days
in the fridge
Track this in StackbaseFree. Your doses, streaks and supplies in one private place.

What it is

Retatrutide acts on three hormone receptors at once. In a 48-week phase 2 trial, people on 12 mg a week lost about 24% of their body weight on average. It is still in phase 3 trials and is not approved anywhere.

How it’s used

  • Injected under the skin once a week, with slow dose increases.

Typical amounts

  • The phase 2 trial started most people at 2 mg a week and raised the dose over several weeks, up to 12 mg.

Good to know

  • Not approved; anything sold now is unregulated.
  • Side effects are like other GLP-1 drugs: nausea, diarrhea, vomiting, and a faster heart rate.
  • Fast weight loss can cost muscle. Eat enough protein and strength train.

Educational information, not medical advice. Check anything you take with a doctor or pharmacist.